🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was conducted to determine the efficacy and safety of GWP42003 c...
Status
Completed
Location
Multiple Locations
Start Date
2012-05-09
Trial ID
NCT01562314
To evaluate the efficacy of GWP42003-P as adjunctive treatment in reducing ...
Status
Completed
Location
Multiple Locations
Start Date
2015-04-28
Trial ID
NCT02224690
Treatments Being Tested
This study consisted of 2 parts: a double-blind (DB) phase and an open-labe...
Status
Completed
Location
Multiple Locations
Start Date
2016-03-11
Trial ID
NCT02564952
Treatments Being Tested
This clinical trial compares topical cannabidiol to placebo in improving ch...
Status
Completed
Location
Mayo Clinic Health System Albert Lea
Start Date
2022-06-09
Trial ID
NCT05388058
Treatments Being Tested
This trial consists of 2 parts: a double-blinded phase and an open-label ex...
Status
Completed
Location
SEIN - Epilepsy Institute in the Netherlands Foundation
Start Date
2016-11-09
Trial ID
NCT02607891
Treatments Being Tested
This 15-19 week study is being conducted by GW Pharma Ltd as a pilot study ...
Status
Completed
Location
Woolpit Health Centre
Start Date
2010-10
Trial ID
NCT01217112
A study to compare the change in symptom severity in participants with schi...
Status
Completed
Location
Multiple Locations
Start Date
2014-02-25
Trial ID
NCT02006628
The major purpose of the Stage 1 is to study the safety and tolerability of...
Status
Completed
Location
University of Colorado School of Medicine
Start Date
2016-10
Trial ID
NCT02818777
Treatments Being Tested
This study is being conducted to evaluate the effects of GWP42003-P on cogn...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-10
Trial ID
NCT04133480
Treatments Being Tested
This trial consists of 2 parts: a double-blinded phase and an open-label ex...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2016-08-31
Trial ID
NCT02544750
Treatments Being Tested